CTCBIO Inc (060590) - Total Liabilities

Latest as of September 2025: ₩77.43 Billion KRW ≈ $52.47 Million USD

Based on the latest financial reports, CTCBIO Inc (060590) has total liabilities worth ₩77.43 Billion KRW (≈ $52.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CTCBIO Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how CTCBIO Inc's total liabilities have evolved over time, based on quarterly financial data. See CTCBIO Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

CTCBIO Inc Competitors by Total Liabilities

The table below lists competitors of CTCBIO Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Spectris PLC LSE:SXS	UK	GBX1.14 Billion
Prestige Wealth Inc. NASDAQ:AURE	USA	$42.54 Million
SDS Group Bhd KLSE:0212	Malaysia	RM77.84 Million
Gmb Korea KO:013870	Korea	₩401.22 Billion
Dsr Wire KO:069730	Korea	₩69.74 Billion
Immutep Ltd AU:IMM	Australia	AU$13.35 Million
Hastings Technology Metals Ltd AU:HAS	Australia	AU$137.26 Million
Firetrade Engineering PCL BK:FTE	Thailand	฿387.68 Million

Liability Composition Analysis (2011–2024)

This chart breaks down CTCBIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 060590 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CTCBIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CTCBIO Inc (2011–2024)

The table below shows the annual total liabilities of CTCBIO Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩84.07 Billion ≈ $56.97 Million	-7.02%
2023-12-31	₩90.42 Billion ≈ $61.27 Million	-1.65%
2022-12-31	₩91.94 Billion ≈ $62.30 Million	+10.48%
2021-12-31	₩83.21 Billion ≈ $56.39 Million	-17.49%
2020-12-31	₩100.86 Billion ≈ $68.35 Million	-9.76%
2019-12-31	₩111.76 Billion ≈ $75.74 Million	+6.62%
2018-12-31	₩104.82 Billion ≈ $71.03 Million	-11.04%
2017-12-31	₩117.82 Billion ≈ $79.84 Million	+20.49%
2016-12-31	₩97.78 Billion ≈ $66.26 Million	+3.50%
2015-12-31	₩94.47 Billion ≈ $64.02 Million	+23.28%
2014-12-31	₩76.63 Billion ≈ $51.93 Million	+31.56%
2013-12-31	₩58.25 Billion ≈ $39.47 Million	-7.49%
2012-12-31	₩62.96 Billion ≈ $42.67 Million	+29.78%
2011-12-31	₩48.52 Billion ≈ $32.88 Million	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$51.04 Million

₩75.31 Billion KRW

Market Cap Rank

#21869 Global

#1318 in Korea

Share Price

₩3150.00

Change (1 day)

-4.83%

52-Week Range

₩3045.00 - ₩7450.00

All Time High

₩18000.00